• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Takei Eriko  武井 江梨子

ORCIDConnect your ORCID iD *help
Researcher Number 40594643
Other IDs
Affiliation (based on the past Project Information) *help 2019 – 2021: 慶應義塾大学, 医学部(信濃町), 助教
Review Section/Research Field
Principal Investigator
Basic Section 54020:Connective tissue disease and allergy-related
Keywords
Principal Investigator
治療標的分子 / B細胞亜分画 / 抗体産生 / 病態モデルマウス / 自己抗体 / B細胞 / シェーグレン症候群
  • Research Projects

    (1 results)
  • Research Products

    (15 results)
  • Co-Researchers

    (1 People)
  •  The exploration of therapeutic target molecules for Sjogrens syndrome focusing on B cell subsetsPrincipal Investigator

    • Principal Investigator
      Takei Eriko
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 54020:Connective tissue disease and allergy-related
    • Research Institution
      Keio University

All 2021 2020 2019

All Journal Article Presentation

  • [Journal Article] Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sjogren’s syndrome2020

    • Author(s)
      Yoshimoto Keiko、Suzuki Katsuya、Takei Eriko、Ikeda Yumi、Takeuchi Tsutomu
    • Journal Title

      Arthritis Research & Therapy

      Volume: 22 Issue: 1

    • DOI

      10.1186/s13075-020-02249-1

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K08890, KAKENHI-PROJECT-19K08919, KAKENHI-PROJECT-19K17916
  • [Presentation] BAFF-BAFF receptor, BR3, axis is involved in activation of monocytes via NF-kB pathways and assists B cell activation in patients with primary Sjogren’s syndrome.2021

    • Author(s)
      Keiko Yoshimoto, Katsuya Suzuki, Yumi Ikeda, Eriko Takei, Tsutomu Takeuchi
    • Organizer
      23rd APLAR Asia-Pasific League of Associations of Rheumatology Congress
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K17916
  • [Presentation] 原発性シェーグレン症候群患者末梢血単球でのBAFF受容体発現亢進にはTLR4シグナル経路が関与する2021

    • Author(s)
      池田由美、吉本桂子、鈴木勝也、武井江梨子、竹内 勤
    • Organizer
      第29回日本シェーグレン症候群学会学術集会
    • Data Source
      KAKENHI-PROJECT-19K17916
  • [Presentation] シェーグレン症候群末梢血単球でのBAFF誘導IL-6産生機構におけるNav1.7チャンネルの関与2021

    • Author(s)
      吉本桂子、鈴木勝也、池田由美、武井江梨子、竹内 勤
    • Organizer
      第29回日本シェーグレン症候群学会学術集会
    • Data Source
      KAKENHI-PROJECT-19K17916
  • [Presentation] Activation of signaling pathways of Toll-like receptor 4 promotes expression of BAFF receptor, BR3 in CD14+CD16+ human monocytes.2021

    • Author(s)
      Yumi Ikeda, Keiko Yoshimoto, Katsuya Suzuki, Eriko Takei, Tsutomu Takeuchi
    • Organizer
      23rd APLAR Asia-Pasific League of Associations of Rheumatology Congress
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K17916
  • [Presentation] 原発性シェーグレン症候群患者末梢血単球でのBAFF受容体発現亢進におけるTLR4シグナルの関与2021

    • Author(s)
      池田由美、吉本桂子、鈴木勝也、武井江梨子、竹内 勤、金子 祐子
    • Organizer
      第8回JCRベーシックリサーチカンファレンス
    • Data Source
      KAKENHI-PROJECT-19K17916
  • [Presentation] Signaling pathways via Toll-like receptor 4 are involved in enhanced expression of BAFF receptor in CD14+CD16+ human monocytes.2021

    • Author(s)
      Yumi Ikeda, Keiko Yoshimoto, Katsuya Suzuki, Eriko Takei, Tsutomu Takeuchi
    • Organizer
      第50回日本免疫学会学術集会
    • Data Source
      KAKENHI-PROJECT-19K17916
  • [Presentation] 原発性シェーグレン症候群患者末梢血単球におけるBAFFシグナルとイオンチャンネルのクロストーク機構の解析2021

    • Author(s)
      吉本桂子、鈴木勝也、池田由美、武井江梨子、竹内 勤
    • Organizer
      第65回日本リウマチ学会総会・学術集会
    • Data Source
      KAKENHI-PROJECT-19K17916
  • [Presentation] 原発性シェーグレン症候群患者末梢血単球ではTLR4シグナル経路の活性化がBAFF受容体発現亢進に寄与する2021

    • Author(s)
      池田由美、吉本桂子、鈴木勝也、武井江梨子、竹内 勤
    • Organizer
      第65回日本リウマチ学会総会・学術集会
    • Data Source
      KAKENHI-PROJECT-19K17916
  • [Presentation] Possible involvement of the voltage-gated sodium channel 1.7 in activation of BAFF signaling in monocytes of patients with primary Sjogren’s syndrome.2021

    • Author(s)
      Keiko Yoshimoto, Katsuya Suzuki, Yumi Ikeda, Eriko Takei, Tsutomu Takeuchi
    • Organizer
      第50回日本免疫学会学術集会
    • Data Source
      KAKENHI-PROJECT-19K17916
  • [Presentation] Signaling pathways via Toll-like receptor 4 are involved in elevated expression of BAFF receptor in monocytes.2020

    • Author(s)
      Yumi Ikeda, Keiko Yoshimoto, Katsuya Suzuki, Eriko Takei, Tsutomu Takeuchi
    • Organizer
      22nd Asia-Pacific League of Associations for Rheumatology Congress
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K17916
  • [Presentation] 原発性シェーグレン症候群患者末梢血単球でのBAFF受容体発現亢進はB細胞活性化および臨床的特徴に関与する2020

    • Author(s)
      吉本桂子、鈴木勝也、武井江梨子、池田由美、竹内 勤
    • Organizer
      第64回日本リウマチ学会総会・学術集会
    • Data Source
      KAKENHI-PROJECT-19K17916
  • [Presentation] 原発性シェーグレン症候群患者末梢血単球でのBAFF受容体発現亢進とB細胞活性化の関与2019

    • Author(s)
      吉本桂子、鈴木勝也、武井江梨子、竹内 勤
    • Organizer
      第28回日本シェーグレン症候群学会・学術集会
    • Data Source
      KAKENHI-PROJECT-19K17916
  • [Presentation] 間質性肺炎合併原発性シェーグレン症候群における臨床像の検討2019

    • Author(s)
      武井江梨子、鈴木勝也、仁科 直、安岡秀剛、竹内 勤
    • Organizer
      第63回日本リウマチ学会総会・学術集会
    • Data Source
      KAKENHI-PROJECT-19K17916
  • [Presentation] ELEVATED EXPRESSION OF BAFF-RECEPTOR IN PERIPHERAL MONOCYTES PROMOTES B CELL ACTIVATION AND CORRELATES WITH CLINICAL MANIFESTATIONS OF PRIMARY SJÖGREN’S SYNDROME.2019

    • Author(s)
      Keiko Yoshimoto, Katsuya Suzuki, Yumi Ikeda, Eriko Takei, Tsutomu Takeuchi
    • Organizer
      EULAR 2019
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K17916
  • 1.  YOSHIMOTO Keiko
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi